Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Liver Neoplasms

bromocriptine has been researched along with Liver Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilbao, I; Egaña, N; García, C; Olaizola, I1
Burshell, AL; Pathak, RD; Tran, TH1
Chen, XP; Ding, L; Guan, J; Li, CL; Wang, HP; Wang, ZH; Zhang, WG; Zhang, ZW1
Cao, B; Chen, XP; Ding, L; Li, CL; Wang, ZH; Zhang, WG; Zhang, ZW1
Cao, B; Chen, XP; Ding, L; Jing, K; Li, J; Zhang, DY; Zhang, ZW; Zhu, P1

Other Studies

5 other study(ies) available for bromocriptine and Liver Neoplasms

ArticleYear
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:10

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide

2017
A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2

    Topics: Adenoma, Islet Cell; Bromocriptine; Chromogranin A; Chromogranins; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Pancreatic Polypeptide; Prolactinoma

2004
Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.
    World journal of gastroenterology, 2005, Sep-28, Volume: 11, Issue:36

    Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromocriptine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; RNA, Messenger; Tumor Necrosis Factor-alpha

2005
[Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2006, Volume: 14, Issue:5

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromocriptine; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger; Tumor Cells, Cultured

2006
[Study on sensitivity to chemotherapy by combination therapy with tumor necrosis factor-alpha and bromocriptine in the multidrug resistant subcell line of HepG2].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Dec-01, Volume: 44, Issue:23

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Bromocriptine; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Necrosis Factor-alpha

2006